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This thesis describes the design and synthesis of triosmium cluster derivatized 
thymine and thymidine analogues using the copper(I)-catalyzed azide-alkyne 
cycloaddition (‘click’ reaction). Two bioconjugation approaches were explored.  
For the first approach, the organic fragment was first synthesized via the ‘click’ 
reaction. In particular, 4-pentynoic acid has been employed in click reactions with 1-
(4-azidobutyl)thymine to afford a novel triazole compound. This ‘click’ product was 
subsequently reacted with Os3(CO)10(NCMe)2, 1, to yield a novel cluster containing 
two triosmium moieties. Further experiments involving other N1-substituted triazoles 
with 1 demonstrated that besides the carboxylic acid group, the triazole moiety also 
reacted with the activated cluster.  
For the second approach, triosmium clusters containing a terminal alkyne or azide, 
and the azide or alkyne derivatized biomolecule, were combined via the ‘click’ 
reaction. The clusters Os3(CO)10(µ-H)(µ-O2CC≡CH) and Os3(CO)10(µ-H)(µ-
O2C(CH2)nN3) have been successfully employed in these reactions, yielding six novel 
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Chapter 1 Organometallic bioconjugation for TEM imaging 
 
1.1 The bioconjugation of organometallics 
Bioconjugation refers to the covalent attachment of synthetic labels to a biomolecular 
moiety. The first example of bioconjugation of organotransitionmetal complexes 
involved the attachment of ferrocene to a synthetic polypeptide.1 Since then, the 
synthesis of many other bioconjugates of organometallic complexes has been 
explored and the term bioorganometallic chemistry, which refers to the synthesis and 
study of organometallic species of biological and medicinal interest, was first coined 
in 1985.2  The structural diversity and certain unique properties of bioorganometallic 
complexes have led to a number of innovative applications in different areas of 
biochemistry, such as pharmaceuticals, bioanalysis and bioimaging.3,4,5 
 
1.1.1 Organometallics drugs  
There is an increasing interest in organometallics pharmaceuticals. Transition metal 
complexes, with their diverse coordination numbers as well as coordination 
geometries, confer novel mechanisms of action and cellular response which are not 
seen with organic compounds.6 Bioorganometallic complexes which are stable 
enough for use as therapeutic agents in cancer treatment has already been 
demonstrated, notably by Sadler,7,8 Jaouen,9 Alberto,10,11 Osella12 and Dyson13 in the 
past decade.  
Ferrocifen, an analogue of tamoxifen in which one of its phenyl ring has been 
replaced by a ferrocene moiety (Figure 1.1), is a potential drug for treating breast 
cancer which is about to enter phase one clinical trial.  
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Tamoxifen (R = H)









Figure 1.1. Structures of tamoxifen (left) and ferrocifen (right). 
 
An important advantage of ferrocifen over its parent compound tamoxifen is its 
activity against both estrogen-dependent and -independent breast cancer cells.14 The 
antiproliferative properties of ferrocifen can be attributed to a combination of the anti-
estrogenic effect of the tamoxifen-like fragment and the cytotoxity attributed to the 
redox properties of the ferrocene moiety.15 Other tamoxifen derivatives containing a 
variety of organometallic moieties such as rhenium carbonyl (CpRe(CO)3),16 
manganese carbonyl (Mn(CO)3),17 and titanocene (Cp2TiCl2),18 have also been 
synthesized.  
Another class of iron-based anticancer drugs is the iron nucleoside analogues.19 
Various iron-containing nucleoside analogues were found to induce apoptosis and one 









Figure 1.2. Structure of iron-containing nucleoside analogue which displays 
antileukemic potency. 
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Other examples of bioorganometallics drugs which have emerged over recent years 
include a ruthenium staurospine analogue which inhibits the activity of glycogen 
synthase kinase 3 (GSK3),20 and triosmium-quinone complexes that show good 
telomerase inhibition and low nonspecific cytotoxicity.21 
Besides showing good telomerase inhibition, triosmium and hexaosmium carbonyl 
clusters have also been shown to posses anticancer activity against four cancer cell 
lines, namely, ER(+) breast carcinoma (MCF-7), ER(−) breast carcinoma (MDA-MB-
231), metastatic colorectal adenocarcinoma (SW620), and hepatocarcinoma (Hep 
G2).22,23  
 
1.1.2 Bioanalysis and imaging 
Transition organometallic complexes have been explored as bioanalytical probes 
using detection techniques that include fluorescence, electrochemical, radioactive and 
infrared. 
The labeling of biological substances with organic fluorescent molecules is a common 
procedure in bioanalysis,24 but there are measurement problems associated with the 
short fluorescence lifetimes and self-quenching effects of organic molecules. In this 
regard, organotransition metal compounds, including ruthenium(II) and rhodium(III) 
complexes, which can serve as good donors with long lifetimes for sensing and 
quenching, have been conjugated to various biomolecules in the development of 
sensitive spectroscopic probes.25,26 It has also been reported that ruthenium(II)-tris-
4,7-diphenyl-1,10-phenanthroline dichloride, Ru(dpp)3Cl2, in a biotinylated 
nanospheres-incorporated form, can be used in competitive immunoassays for 
streptavidine.27 
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Ferrocene, which possesses reversible and stable redox properties, can be employed 
as electrochemical probes. For example, DNA hybridization events can be detected by 
the site-specific incorporation of ferrocenyl derivatives into DNA oligonucleotides. 
This electrochemical technique, which is rapid and accurate, can be extended to the 
detection of specific genes associated with diseases.28 
186Re and 99Tc complexes conjugated to antibodies have been used as tracers in 
radioimmunoassay.29,30 Much research related to 186Re and 99Tc for diagnostic 
imaging has also been reported. For instance, the estrogen derivative of rhenium has 
been used in the selective imaging of breast tumor.31,32 A thymidine derivative of 
technetium has also been synthesized and evaluated as a potential proliferation marker 
(Figure 1.3).33 However, the development of radioactive bioprobes has been limited 
by drawbacks associated with radioactivity, such as health hazards and waste disposal 














Figure 1.3. Structure of 99mTc-MAMA-propyl-thymidine. 
 
Organometallic carbonyl complexes, which exhibit intense carbonyl absorption bands 
in the mid-IR region (2200 − 1800 cm−1), have been used as bioprobes in carbonyl 
metalloimmunoassay (CMIA).35 In CMIA, suitable tracers are first synthesized by the 
attachment of stable organometallic complexes to derivatives of the analytes to be 
assayed. A known quantity of the tracer is then incubated in the presence of a fixed 
but smaller quantity of antibody and a variable quantity of the analyte present (Figure 
 5
1.4). After incubation, the free and bound fractions of the tracer are separated and 














Figure 1.4. Schematic diagram of CMIA.  
 
CMIA can approach the high sensitivity detection range of radioimmunoassays 
(around 300 fmol) with minimal interference from organic chromophores. This was 
first demonstrated in an estrogen receptor binding assay with an estradiol analogue 







Figure 1.5. Structure of Cr(CO)3 derivative of estradiol.  
 
Other biomolecules that have been assayed successfully by CMIA include 
phenolbarbital, phenytoin and carbamazepine.37,38,39 In addition, water-soluble 
triosmium carbonyl clusters have also been successfully employed as organometallic 
carbonyl tags for cell imaging using an IR microscope.40  




1.2 Visualization of DNA 
In 1952, Hershey and Chase reported that DNA plays a role in determining 
biochemical activity.41 Since then, the imaging of DNA becomes of great interest for 
a better understanding of genetic properties. Various techniques have been used in the 
visualization of DNA. Visible light, ultraviolet and laser confocal scanning 
microscope can be used to image large DNA molecules isolated in liquid media.42,43 
On the other hand, nucleic acids can be observed under physiological conditions and 
at nanometric resolution using scanning tunneling microscopy (STM) and atomic 
force microscopy (AFM) techniques.44 However, STM and AFM provide only surface 
topographs, and the accuracy and reproducibility of the images produced depend on 
the geometrical properties of the tips used to scan the sample. DNA molecules can 
also be imaged by transmission electron microscopes (TEM) as long as a certain 
amount of contrast exists. Some aspects of the imaging of DNA by TEM will be 
described in the following section.  
 
1.2.1 Imaging of DNA by TEM 
TEM is often used to study the ultrastructural organization of the nuclear components. 
Different techniques were proposed to distinguish DNA from the other 
macromolecules present in the nucleus in situ. These techniques include the Feulgen-
like reaction with osmium ammine, autoradiography, immunocytology, and 
hybridization methods.  
The use of electron opaque stains, such as osmium ammine, gives a high contrast of 
the stained DNA structures and permits a DNA molecule of 2 to 3 nm to be clearly 
visualized.45 However, a very precise localization of DNA using staining methods is 
not always possible.  
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In autoradiography, the tissue section which is placed in contact with a photographic 
emulsion is first incubated with a suitable radiolabeled molecule, such as 3H-
thymidine. Some of the ionizing particles emitted by the radioisotope will reach the 
silver bromide crystals in the photographic emulsion and a latent image will be 
formed. The distribution of the silver grains in the resulting autoradiograph indicates 
the location of the radiolabeled molecule.46 This approach has a relatively low spatial 
resolution and usually a long exposure time of autoradiograms is required.47 In 
addition, the use of radioactive material necessitates strict licensing requirements.  
The immunocytological approach makes use of the highly specific reaction between 
antigen and antibody, whereby immune reagents locate antigens in situ.48 To detect 
nucleic acids using this approach, an indirect immunogold labeling procedure which 
involves colloidal gold (gold nanoparticles) coupled with immunoglobin, is 
commonly used (Figure 1.6).49  The first step of this procedure involves the 
incubation of an ultrathin section in a droplet of primary antibody raised against a 
specific tissue antigen. The ultrathin section is then incubated in a secondary antibody 
coupled to colloidal gold to reveal the antigen-antibody complex. The distribution of 
this specific tissue antigen on the cell can thus be shown by the presence of the gold 
probes on the section surface. This approach is sensitive and specific. However, 







coupled to colloidal gold
 
Figure 1.6. Schematic diagram of basic immunogold labeling procedure. 
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The hybridization approach allows for specific nuclei acid sequences to be revealed in 
the cellular environment. The procedure involves denaturation of the native DNA 
followed by the renaturation of the target nucleic acid and the probe to give hybrids. 
Three types of probes – double-stranded DNA, single-stranded DNA and 
oligonucleotides probes – can be used. The labels used for this approach can be 
divided into two categories; radioactive labels which require autographic detection, 
and antigenic labels which require immunocytological detection.51 This approach 
allows specific nuclei sequences to be located and is useful when the morphological 
context is important.  
 
1.2.2 Use of site-specific clusters labels in the TEM imaging of DNA 
Heavy-atom compounds, such as osmium-ammine, have long been employed to stain 
and increase the contrast of biological specimens in TEM imaging. These stains are 
usually employed as bulk deposits because single atoms cannot be revealed in most 
electron microscopes. Hence, higher resolution studies, such as the marking of active 
sites and mapping of small complementary sequences, usually cannot be achieved by 
these staining methods.52 
Another commonly used reagent in TEM is colloidal gold. The high contrast of gold 
particles facilitates their identification. In addition, colloidal gold particles of various 
sizes can be easily synthesized,53 and double-labeling experiments can be performed 
on a single preparation.54 However, the manufacture of smaller colloidal gold 
particles (3 nm and below) usually results in particles with a wide range of diameters. 
Furthermore, the common colloidal gold conjugation procedure requires the addition 
of a stabilizer, such as polyinylpyrrolidone, or BSA, to minimize aggregation.55 
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Hence, colloidal gold label is also not a suitable candidate for higher resolution 
studies.  
To achieve higher resolution, the use of an undecagold cluster, Au11(P(C6H5)3)7, and a 
larger gold cluster which contains around 67 gold atoms, Au1.4nm, as labels have been 
studied.55,56 There are several advantages associated with the use of gold clusters. 
Unlike colloidal gold, these clusters have uniform sizes.55 The clusters are covalently 
bonded to probes, such as antibody, hence gold cluster linked probes are usually very 
stable.57 As compared to colloidal gold, the smaller gold clusters give better 
penetration into tissues.58 Most importantly, gold clusters labels offer better resolution 
and have been used to mark specific sites of single biomolecules.59,60 Besides gold 
clusters, various other heavy atoms clusters, including tetramercury and 
undecatungsten, have been bioconjugated to produce high-resolution labels visible 
under the electron microscope.61,62  
Another class of metal clusters which can potentially also be used as labels for the 
imaging of DNA is the transition metal carbonyl clusters. Osmium carbonyl clusters 
are of potential for microscopy imaging because they are relatively inert towards air 
and water, and they offer multiple sites for the attachment of various ligands.63,64,65 
Furthermore, the transition metal carbonyl cluster exhibits strong CO stretching in the 
mid-IR region and can serve as both an IR spectroscopy and an electron microscopy 
tag. Triosmium carbonyl clusters, which are visible under high resolution scanning 
TEM (STEM), can provide the highest resolution.66 However, clusters containing 
more heavy atoms may be required if a high dose of STEM, which can be damaging 
to the biological samples, is to be avoided. Thus, high nuclearity osmium and 
ruthenium clusters, such as hexaosmium and decaruthenium clusters, can be used for 
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conventional electron microscopy. Alternatively, two or more triosmium clusters can 
be linked to each biomolecular probe to increase the electron density of each probe. 
 
1.3 Aim of project 
The aim of this project is to study the conjugation of triosmium carbonyl clusters to 
thymine and thymidine derivatives. These triosmium cluster derivatized thymine and 
thymidine analogues can be incorporated into oligonucleotides to be used in TEM for 
obtaining structural information of DNA. The conjugation method which has been 
chosen to be investigated is the copper(I)-catalyzed azide-alkyne cycloaddition 
(‘click’ reaction).  
 
1.3.1 Copper(I)-catalyzed azide-alkyne cycloaddition (‘click’ reaction) 
The concept of copper(I)-catalyzed azide-alkyne cycloaddition (‘click’ reaction) was 
introduced by Sharpless and co-workers as an ‘atom efficient’ and reliable means of 
coupling complex molecules.67 Typical ‘click’ reaction conditions involved the use of 
copper sulfate and sodium ascorbate to generate the copper(I) species in situ. 
Alternatively, catalytic amounts of copper(I) salts, such as cuprous bromide or iodide, 
with 1 to 5 equivalents of base can be used. The ‘click’ reaction usually proceeds 
smoothly at room temperature and produces regiospecific 1,4-disubstituted 1,2,3-









Scheme 1.1. General reaction scheme for the copper(I)-catalyzed azide-alkyne 
cycloaddition (‘click’ reaction).  
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The ‘click’ reaction has been the subject of several reviews,68-71 finding applications 
in various fields of chemistry, such as synthesis,69 materials science,70 and chemical 
biology71. In addition, various thymidine derivatives have been employed in the 
copper(I)-catalyzed azide-alkyne ‘click’ reaction.72,73 This synthetic strategy has also 
been used for the derivatization of ferrocene,74,75 diruthenium complexes76 and the 
dodecaborate anion.77 To the best of our knowledge, despite its widespread 
applications, ‘click’ chemistry has not been used as a means of functionalizing 
organometallic clusters. 
 
1.3.2 Synthetic strategy 
Two general approaches for the synthesis of the target bioconjugates were explored; 
the retrosynthetic analysis is given in Scheme 1.2. Initial disconnection at a represents 
a strategy whereby the organic fragment is put together first via ‘click’ reaction 
followed by reaction with the “Os3(CO)10” synthon X. The synthetic equivalent for X 
includes clusters such as Os3(µ-H)(µ-OH)(CO)10,78 and Os3(CO)10(NCMe)2, 1.79 For 
initial disconnection at b, triosmium clusters containing the appropriate functional 
groups have to be first synthesized while the ‘click’ reaction is carried out in the last 
step. The results obtained using the afore-mentioned disconnections will be described 
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Chapter 2 Results and discussion 
 
As mentioned in the previous chapter, the target bioconjugates are accessible via two 
different routes as shown by the retrosynthetic analysis below (Scheme 2.1). The 
forward syntheses for both routes involve a “click” reaction and the formation of a 
carboxylate-bridged triosmium cluster, and differ in the sequence of these reactions. 

































Scheme 2.1. Retrosynthetic analysis of a target bioconjugate.  
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2.1 First approach: initial disconnection at a 
The first approach, which involves initial disconnection at a, has the advantage that 
the expensive cluster is put in place at the last stage. Activated triosmium clusters, 
such as Os3(CO)10(NCMe)2, 1, and Os3(CO)10(µ-H)(µ-OH), react with carboxylic 
acids to form the hydridocarboxylato derivatives, Os3(CO)10(µ-H)(µ-O2CR).1 The 
‘click’ product between the alkynoic acid and an azido derivative of 
thymine/thymidine compounds may therefore be expected to bind to a triosmium 
cluster via the carboxylic acid group. An anticipated problem, however, is that the 
yield for the incorporation of the triosmium cluster is known to depend on the nature 
of the carboxylic acid.2  
 
2.1.1 Trial ‘click’ reactions between alkynoic acids, 2, and benzyl azide, 3 
Trial reactions involving propiolic acid, 2a, and 4-pentynoic acid, 2b, with benzyl 
azide, 3, were conducted to determine suitable conditions for ‘click’ reactions 


















Scheme 2.2. Reaction between alkynoic acids and benzyl azide. 
  
Table 2.1.  Conditions and products of the trial ‘click’ reactions between alkynoic 
acids and benzyl azide. 
 
Reactants Conditions Products 
2a + 3 CuSO4, sodium ascorbate, THF/ H2O Unidentified 
2a + 3 CuI, 2,6-lutidine, DIPEA, acetonitrile 4a (5 %) + 5 (35 %) 
2b + 3 CuI, DIPEA, acetonitrile 4b (65 %) 
 2b + 3 CuSO4, sodium ascorbate, THF/ H2O 4b (69 %) 
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In the reaction involving 2a, the target compound, 4a, was only obtained in low yields; 
the major product was identified as the decarboxylated ‘click’ product, 5. This 
decarboxylation of the carboxyl group under ‘click’ conditions has also been obtained 
for a similar reaction involving polymer-bound azides and 2a.3 A one-pot synthesis of 
4a, has also recently been reported, but the yield obtained was still low (20 %).4 The 
use of 2a as a click synthon was thus abandoned. 
On the other hand, the reaction of 2b using two different sets of conditions both 
afforded the target compound 4b in moderately high yields. This result is also in 
contrast with that reported recently,5 in which the yield of 4b was significantly lower 
(35 %) and has been attributed to the intramolecular cyclization of 2b.  
 
2.1.2 ‘Click’ reaction of alkynoic acids and an azidothymine 
With the successful ‘click’ reaction employing 2b above, the analogous reaction 
between 2b and 1-(4-azidobutyl)thymine, 6, was carried out (Scheme 2.3). A brown 
oil was obtained after the solvent was removed under vacuum. Attempts to purify the 
compound by extraction and column chromatography failed, probably due to the 
polarity of the product. The product, 7, was eventually purified by recrystallization 
from methanol to yield a small amount of pure white solid (yield = 19 %), and was 



















7  (19 %)62b
Scheme 2.3. Reaction between 4-pentynoic acid, 2b, and 1-(4-azidobutyl)thymine, 6. 
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For use as a biomolecular probe via electron microscopy, it would be desirable to 
have a higher electron density. This can, in principle, be achieved by attaching two or 
more triosmium clusters to each biomolecule. To achieve this, a ‘click’ product 
containing two carboxylic groups in close proximity must first be synthesized. An 
attempt was made towards this goal with 2-prop-2-ynyl-malonic acid, 9. The ‘click’ 
reaction between 6 and 9 gives the target compound, 10, albeit in low yields (Scheme 
























6 10  (10 %)9  
Scheme 2.4. Reaction of 2-prop-2-ynyl-malonic acid, 9, and 6. 
 
Having successfully synthesized 7, the elaboration towards 8 via the reaction between 
































Scheme 2.5. Attempted synthesis of 8. 
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The 1H NMR spectrum of A1 exhibited an osmium-hydride resonance at −10.47 ppm, 
typical of an Os3(CO)10(µ-H)(µ-O2CR) cluster. However, the IR spectrum in the CO 
stretch region is more complicated than that of a typical Os3(CO)10(µ-H)(µ-O2CR) 
cluster. The FAB-MS spectrum shows a [M+H]+ peak at 2022.5, indicating that the 
molecular formula of A1 is C34H19N5O24Os6; that A1 contains two Os3(CO)1O 
moieties was unexpected. Although 1 is known to react with N-heterocyclic 
compounds, such as benzotriazole and benzimidazol,6,7 to the best of our knowledge, 
no reaction of N1-substituted 1,2,3-triazoles with triosmium clusters has been 
reported. Thus, both 1-benzyl-1H-[1,2,3]triazole, 5, and 3-(1-benzyl-1H-
[1,2,3]triazol-4-yl)-propionic acid, 4b, were reacted with 1, to investigate the 
reactivity of N1-substituted 1,2,3-triazoles towards activated triosmium clusters.  
 
2.1.3 Reaction of Os3(CO)10(NCMe)2, 1, and N1-substituted 1,2,3-triazoles 
1-Benzyl-1H-[1,2,3]triazole, 5, reacts with 1 to give one major product, B1, in high 























Scheme 2.6. Reaction of 1 and 5. 
 
The compound 4b, like 7, contains both a carboxylic acid group and a triazole group. 
The reaction between 1 and 4b yields a mixture of products (Scheme 2.7); the two 
major products, A2 and B2, were characterized by 1H NMR, IR spectroscopy and 












































Scheme 2.7. Reaction of 1 with 4b and 7. 
 
Table 2.2. Characterization data of the compounds B1, A2 and B2. 
 IR (CH2Cl2, cm−1) 
νCO 




B1 2084m, 2029s, 
2018vs, 2003m, 
1975m, 1956w 
(CDCl3) 7.69 (d, 1H, triazole), 7.53-
7.51 (m, 3H, Ph),   7.33-7.30 (m, 
2H, Ph), 7.14 (d, 1H, triazole), 5.26 
(d, 1H, CH2Ph), 5.16 (d, 1H, CH2Ph)
C19H9N3O10Os3 
B2 2085m, 2026s, 
2017vs, 1975m, 
1956w 
(acetone-d6) 8.46 (s, 1H, triazole), 
7.42 (br s, 5H, Ph), 5.58 (br s, 1H, 
CH2Ph), 5.43 (br s, 1H, CH2Ph), 
2.70 (br s, 2H, CH2), 2.43 (br s, 2H, 
CH2) 
C22H13N3O12Os3 
A2 2114w, 2083m, 
2077s, 2063s, 
2029vs, 2017vs, 
1975m, 1950 m 
(CDCl3) 7.54-7.52 (m, 3H, Ph), 
7.31-7.38 (m, 2H, Ph), 6.77 (s, 1H, 
triazole), 5.19 (d, 1H, CH2Ph), 5.05 
(d, 1H, CH2Ph), 2.58-2.52 (m, 4H, 




The νCO patterns of B2 and B1 are similar. Hence, the structure of B2 should be 
similar to that of B1. The νCO patterns of A2 and A1 are similar and an osmium-
hydride resonance was observed at around −10.5 ppm in the 1H NMR spectra of both 
A2 and A1. Hence, the structures of A2 and A1 should be similar.  
The νCO pattern of A can be regarded as the overlap of the spectrum of a typical 
Os3(CO)10(µ-H)(µ-O2CR) cluster, which has the highest energy band at 2113-2114 
cm−1, and that of B, which has the highest energy band at 2084 cm−1 (Figure 2.1).  
19502000205021002150  
Figure 2.1. νCO pattern of A and B. 
   
Clusters A and B were unstable in solution; precipitate was observed when these 
compounds were left to stand in solution. The 1H NMR spectrum also showed 






     2150                     2100                    2050                    2000                  1950 
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As mentioned in the above section, the bonding of N1-substituted 1,2,3-triazoles to 
triosmium clusters has not previously been described in the literature. As such, in the 
absence of conclusive single X-ray crystallographic studies, DFT calculations were 
carried out to evaluate possible structures of A and B. The geometries of B1, as well 
as those of a simpler analogue, in which the benzyl group is replaced by a methyl 
group, were optimized using the B3LYP18,9 density functional method with SBKJC10 
basis set. The possibility of bonding with both N1 and N3 of the triazole ring to the 
Os3 core was deemed less likely, and indeed, when modeled, converged towards a 
geometry having bound N2 and N3. Consequently, only two geometries for each Os3 
compound, corresponding to bindings with either N1N2 or N2N3, were investigated.  
The optimized geometries are shown in Figure 2.2. The trapezoidal four-membered 
Os2N2 rings are markedly distorted in complexes binding through N1 and N2, 
presumably due to steric hindrance of the substituent on N1. For the same reason, it is 
also noted that only the N2N3 isomers have a triazole ring that is approximately 
perpendicular to the Os3 plane.  
As presented in Table 2.3, the Os-N bond lengths of the N2N3 complexes were found 
to be similar to those in 1, whereas those in the N1N2 isomers were longer. In 
particular, the Os-N1 bond distance in Os3(CO)10(N1N2benzyltriazole) was found to 
be greater than 4.3 Å, indicating an absence of bonding via N1. An examination of the 
Os-Os bond lengths also showed that the Os atoms in the N1N2 isomers form scalene 
triangles. Those of the N2N3 isomers, however, define approximate isosceles 
triangles, with the shortest side defined by the two N-bound Os atoms. Again, we note 









Figure 2.2. Optimized geometries of (a) Os3(CO)10(N1N2methyltriazole), (b) 
Os3(CO)10(N2N3methyltriazole), (c) Os3(CO)10(N1N2benzyltriazole) and (d) 
Os3(CO)10(N2N3benzyltriazole). 
 
The ∆G of each of the gas phase reactions of 1 with the respective triazole are also 
listed in Table 2.3. For both triazole ligands, the complex with N2N3 bonded to the 
Os3 core has significantly lower energy – and thus more likely to be formed – than the 
corresponding N1N2 isomer. Taken together, these computational results suggest that 
(a)  (b)  
(c)  (d)  
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in Os3(CO)10(N1-substituted 1,2,3-triazole) complexes, a cluster-triazole bonding via 
both N2 and N3 appears to be the most likely. 
 
Table 2.3.  Selected results from DFT studies of Os3(CO)10(N1-substituted 1,2,3-
triazole) complexes, in comparison with 1. 
 
Selected bond lengths / Å Cluster ∆G / 
kJ mol−1 Os-N1 Os-N2 Os-N3 Os-Os 
Os3(CO)10(N1N2methyltriazole) 240.2 2.42017 2.21833 − 3.02076 
2.91507 
2.80438 
Os3(CO)10(N2N3methyltriazole) 35.7 − 2.14394 2.15335 2.95892 
2.96303 
2.82542 
Os3(CO)10(N1N2benzyltriazole) 172.8 4.31265 2.26402 − 2.92542 
2.69710 
2.85386 




(from DFT calculations) 




(from crystal data)11 





2.2 Second approach: initial disconnection at b 
Retrosynthetic analyses for initial disconnection at b, gives rise to two sets of 
synthons (Scheme 2.8). That the ‘click’ reaction is in the last step reduces possible 
side reactions for in vivo bioconjugation as both the azide and terminal alkyne 







































Scheme 2.8. Retrosynthetic analyses involving the second strategy. 
 
Clusters containing terminal alkynes or azide groups are required for the ‘click’ 
reactions. To the best of our knowledge, the only known representative of the former 
is Os3(CO)10(µ-H)(µ-O2CC≡CH), 11a, while there is no known representative for the 
latter. However, the synthesis of similar carboxylate-bridged triosmium clusters 
containing a terminal alkyne or azide group from the reaction of activated triosmium 
clusters with the respective carboxylic acids should be feasible.  
 
2.2.1 Synthesis of triosmium clusters containing terminal alkyne  
Cluster 11a can be synthesized from the reaction of 1 with propiolic acid, 2a.13 In this 
reaction, 11a was the major cluster product, isolated in moderately high yield. 
The synthesis of Os3(CO)10(µ-H)(µ-O2CCH2CH2C≡CH), 11b, using a similar 
procedure, was also attempted. However, we observe that in the reaction of 1 with 4-
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pentynoic acid, 2b, the alkyne group is more reactive towards the triosmium cluster 

























n =φ; 11a (50 %)





Scheme 2.9. Reaction of 1 and alkynoic acids. 
 
The target compound, characterized by 1H and 13C NMR, IR spectroscopy and FAB-
MS, was only obtained in low yields. The main product was identified as Os3(CO)9(µ-
CO)(µ3,η2 -HCCCH2CH2CO2H), 12, on the basis of 1H NMR and IR spectroscopy, 
and by a single crystal X-ray crystallographic study. In view of its low yield, 11b was 
not used for further studies of the ‘click’ reaction. 
The crystal of 12 contained two crystallographically independent molecules, one of 
which, together with selected bond lengths (Å), is shown in Figure 2.3. The cluster 
core of 12 resembles that of other alkyne-bridged triosmium clusters.14 The alkyne is 
coordinated to the cluster with two σ bonds (Os(1)-C(2) and Os(2)-C(1)) and donation 
of π electrons to the Os(3) atom. 
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Figure 2.3.  ORTEP diagram for molecule B of 12. (Thermal ellipsoids are drawn 
at 50 % probability level. The hydrogen atoms have been omitted for 
clarity.) For molecule A, Os(1)-C(2) = 2.103(9), Os(2)-C(1) = 
2.120(9), Os(3)-C(1) = 2.188(9), Os(3)-C(2) = 2.269(10). For 
molecule B, Os(1)-C(2) = 2.117(10), Os(2)-C(1) = 2.109(11), Os(3)-
C(1) = 2.258(9), Os(3)-C(2) = 2.285(10). 
 
The propensity of the alkyne group in 4-pentynoic acid, 2b, to bind to the triosmium 
clusters, is not observed in reactions involving other alkynoic acids.13,15 Deeming et al. 
has shown that the alkyne group in propiolic acid, 2a, can only be attached to the 
triosmium moiety after 11a, the initial product formed between the reaction of 1 and 
2a, was reacted with more 1 (Scheme 2.10).13 This difference in reactivity of propiolic 
acid, 2a, and 4-pentynoic acid, 2b, was studied computationally. Our computational 
studies, using semi-empirical PM6 method, suggested that the HOMO of 2b, unlike 
that of 2a, has a relatively higher electron density on the alkyne group. The proximity 
of the carboxylic and alkyne groups in 2a may have an influence on the electronic 
properties of both functional groups. The low yield of 11b is thus related to the higher 
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reactivity of the C≡C moiety in 2b, and suggests that one approach to increase its 






















Scheme 2.10. Reaction of 11a and 1.  
 
The availability of a cluster such as {Os3(CO)10(µ-H)(µ-O2C)}2CHC≡CH, 13, would 
allow for bioconjugation of what is effectively a hexametallic moiety. In an attempt to 
synthesize 13, two equivalent of 1 was also reacted with 2-prop-2-ynyl-malonic acid, 
9, at room temperature (Scheme 2.11). The major product of this reaction, isolated as 
a yellow solid, was characterized by 1H NMR and FAB-MS, and a single crystal X-









































Scheme 2.11. Reaction of 1 with 2-prop-2-ynyl-malonic acid, 9. 
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An ORTEP plot showing the molecular structure of 14, together with selected bond 
lengths (Å), is shown in Figure 2.4.  
 
Figure 2.4. ORTEP diagram for 14. (Thermal ellipsoids are drawn at 50 % 
probability level. The organic hydrogen atoms have been omitted for 
clarity.) Os(1)-O(1) =2.129(4), Os(2)-O(2) = 2.144(4). 
 
Transition metal complexes are known to catalyze the cyclization of alkynoic acids to 
give enol lactones.16,17 It is thus possible that the formation of 14 proceeded via the 
attachment of one carboxylic acid group to the cluster followed by the addition of the 
other carboxylic acid across the triple bond; only the exocyclic enol lactone, the 
Markonikov addition product, was observed.18  
To avoid the cyclization of the alkynoic acid, an alternate synthesis of 13 was 
attempted. The cluster {Os3(CO)10(µ-H)(µ-O2C)}2CH2, 15, obtained from the reaction 
of 1 with malonic acid,15 was reacted with sodium hydride and propargyl bromide. 
However, unlike the analogous reaction involving diethyl malonate, the alkylation of 
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15 was not successful; there was no reaction even after stirring at room temperature 

























Scheme 2.12. Attempted alkylation of {Os3(CO)10(µ-H)(µ-O2C)}2CH2, 15. 
 
2.2.2 Synthesis of triosmium clusters containing azide  
The clusters Os3(CO)10(µ-H)(µ-O2CCH2CH2N3), 16a, and Os3(CO)10(µ-H)(µ-
O2CCH2CH2CH2CH2CH2N3), 16b, were obtained in low to moderate yields from the 
reaction between 1 and the respective azidoalkanoic acids (Scheme 2.13). The poor 

















n=2:  16a  (19%)




Scheme 2.13.   Reaction of 1 with azidoalkanoic acids. 
 
An alternative route to 16a via azidation of Os3(CO)10(µ-H)(µ-O2CCH2CH2Br), 17, 
was attempted (Scheme 2.14). Cluster 17 was obtained in high yield from the reaction 
of 1 and 3-bromopropionic acid. However, the reaction of 17 with sodium azide20 did 
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not proceed, while the reaction with trimethylsilylazide, in the presence of 
tetrabutylammonium fluoride,21 afforded an unstable orange compound which has not 














17 16a  
Scheme 2.14. Attempted azidation of Os3(CO)10(µ-H)(µ-O2CCH2CH2Br), 17.  
 
2.2.3 ‘Click’ reactions  
The thymine and thymidine derivatives,  1-(4-azidobutyl)thymine, 6, 3-(4-
azidobutyl)thymidine, 18, 5’-azido-5’-deoxythymidine, 19, and 3’-azido-3’-
deoxythymidine, 20, underwent copper(I) catalyzed azide-alkyne ‘click’ reaction with  


















Scheme 2.15.  Reaction of 11a with azide derivatized thymine and thymidine. 
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Table 2.4.  Triosmium cluster derivatized thymine and thymidine analogues 
synthesized from ‘click’ reactions involving cluster 11a and organic azides. 
 






















































































20 24 (62 %) 
 
The ‘click’ products were obtained in moderately high yields. In section 2.1, we have 
found that propiolic acid was not a good ‘click’ synthon due to decarboxylation of the 
carboxyl group; this problem can be avoided with the use of 11a.    
Although it is desirable to have the cluster compound as the limiting reagent due to its 
relatively higher costs vis-à-vis the organic reagent, we found that separation of the 
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excess azide compound from the ‘click’ product is difficult due to similarities in their 
polarities. As such, the cluster precursor was used in excess.   
The products 21-24 were characterized by 1H and 13C NMR, IR spectroscopy and 
FAB-MS.  As expected, the νCO stretches of the products are similar to those of the 
cluster precursor. In addition, the 1H NMR spectra of all the products display an 
osmium-hydride resonance in the −10.2 ppm region, typical of an Os3(CO)10(µ-H)(µ-
O2CR) cluster.1 1H NMR spectra of the products also show the triazole H peak at 
around 7.9 ppm, while in the 13C NMR spectra, the triazole C and CH peak show up 
at around 142 and 128 ppm, respectively.  
The structure of 21 has also been confirmed by a single X-ray crystallographic study. 
An ORTEP plot showing the molecular structure of 21, together with selected bond 
lengths (Å), is shown in Figure 2.5.  
 
Figure 2.5.  ORTEP diagram for 21. (Thermal ellipsoids are drawn at 50 % 
probability level. The organic hydrogen atoms have been omitted for 
clarity.) Os(1)-O(41) = 2.129(3), Os(2)-O(42) = 2.138(3), C(42)-C(46) 
= 1.372(6), N(43)-N(44) = 1.313(5), N(44)-N(45) = 1.351(5), N(45)-
C(46) = 1.337(6), N(45)-C(47) = 1.458(6). 
 
 37
The geometry of the 1,2,3-triazole group (N45-N44-N43-C42-C46) in 21 confirms the 
regiospecificity of the Cu catalyzed azide-alkyne ‘click’ reaction that was reported in 
previous studies.22 In addition, the overall geometry of the triosmium core does not 
differ from that of other Os3(CO)10(µ-H)(µ-O2CR) clusters.23   
A click reaction involving a reversal of the moieties, viz., between cluster 16, and 3-
(2-propyn-1-yl)thymidine, 25, has also been attempted, and afforded 26 in moderate 
yields (Scheme 2.16). The products were characterized by 1H and 13C NMR, IR 
spectroscopy and FAB-MS. The IR spectra, like those of 21-24, were typical of an 
Os3(CO)10(µ-H)(µ-O2CR) cluster. In the 1H NMR, the osmium-hydride and the 
triazole proton resonances show up at −10.5 and 7.6 ppm, respectively. In the 13C 































n=2: 26a (52 %)





Scheme 2.16 Reaction of 16 with 3-(2-propyn-1-yl)thymidine, 25. 
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2.3 Concluding remarks 
Two general approaches to the synthesis of bioconjugates of thymine/thymidine with 
triosmium carbonyl clusters via copper(I)-catalyzed azide-alkyne cycloaddition 
(‘click’ reaction) were explored. The first involves the synthesis of a carboxylic acid 
derivative of thymine via a ‘click’ reaction between an alkynoic acid and 1-(4-
azidobutyl)thymine. Reaction of this ‘click’ product with the “lightly stabilized” 
cluster, Os3(CO)10(NCMe)2, 1, yielded a novel cluster which appeared to contain two 
triosmium moieties through reaction with the carboxylic acid as well as the triazole 
functionalities. The latter was corroborated by reactivity studies on other N1-
substituted triazoles with 1, which yielded products which were unstable in solution 
and have been characterized by 1H NMR, IR spectroscopy and FAB-MS. This 
synthetic approach leads to the formation of unstable compounds and is thus unlikely 
to be suitable as a general approach for bioconjugation with triosmium carbonyl 
clusters. 
The second approach involves the ‘click’ reaction of triosmium clusters containing a 
terminal alkyne or azide group with the corresponding azide or alkyne derivatized 
biomolecule. The synthesis of triosmium clusters containing terminal alkynes met 
with variable success. The cluster Os3(CO)10(µ-H)(µ-O2CC≡CH), 11a, was obtainable 
in moderately good yield from the reaction of 1 with propiolic acid, while the reaction 
with 4-pentynoic acid afforded the target compound 11b only in low yield, giving the 
alkyne-bridged triosmium cluster Os3(CO)9(µ-CO)(µ3,η2 -HCCCH2CH2CO2H), 12, as 
the major product. Semi-empirical computational studies suggest that the difference in 
reactivity lies in the different nature of the HOMOs. In the reaction with 2-prop-2-
ynyl-malonic acid, cyclization of the alkynoic acid occurred to give a cluster 
containing an enol lactone, viz., Os3(CO)10(µ-H)(µ-O2CC5H5O2), 14. Similar 
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undesirable side reactions are also observed in the syntheses of clusters containing 
azide functionalities. For the clusters which were available in reasonable yields, such 
as 11a and 16, however, they have been successfully employed in ‘click’ reactions 
with various thymine and thymidine derivatives to yield novel triosmium clusters. In 
these copper(I)-catalyzed azide-alkyne ‘click’ reactions, the cluster precursors have 
been employed as either the azide or alkyne moiety, and various organic reactants 
have also been successfully coupled to the clusters. This second approach is therefore 
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Chapter 3 Experimental 
 
3.1 General experimental 
All manipulations were carried out using standard Schlenk techniques under an inert 
argon atmosphere. Solvents that were used for reactions were distilled over the 
appropriate drying agents under argon before use. 1D and 2D NMR spectra were 
recorded on a Bruker ACF300, AMX500 or DRX 500 FTNMR spectrometer with 
chemical shifts referenced to residual solvent peaks in the respective deuterated 
solvents. Infrared spectra were recorded on a Shimadzu Prestige-21 FTIR 
spectrometer. FAB (3-nitrobenzyl alcohol as matrix), CI, EI amd ESI spectra were 
recorded on Finnigan MAT95XL-T, JEOL MS700, Micromass VG7035 and 
MATLCQ spectrometers respectively. Elemental analyses were performed by the 
microanalytical laboratory at NUS or the service de microanalyse ICSN-CNRS. 
The compounds benzyl azide, 3,1 1-(4-bromobutyl)thymine2, Os3(CO)10(NCMe)2, 1,3 
Os3(CO)10(µ-H)(µ-O2CC≡CH), 11a,4 {Os3(CO)10(µ-H)(µ-O2C)}2CH2, 15,5 3-
azidopropionic acid and 6-bromohexanoic acid,6 5’-azido-5’-deoxythymidine, 19,7 
and 3-(2-propyn-1-yl)thymidine, 25,8 were prepared according to reported procedures. 
All other reactants and reagents were purchased from commercial sources and used as 
supplied without further purification. 
 
3.2 Trial ‘click’ reaction of propiolic acid, 2a, and benzyl azide, 3 
First attempt 
Compounds 3 (132 mg, 0.991 mmol) and 2a (68 mg, 0.97 mmol) were dissolved in 
THF (10 ml) and water (4 ml). Copper sulfate (10 mol %) in water (2 ml) and sodium 
ascorbate (40 mol %) in water (4 ml) were added and the reaction mixture was stirred 
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at room temperature for 16 h. THF was removed under vacuo and 0.1 N HCl was 
added to acidify the solution to pH 3. The crude product was extracted with ethyl 
acetate (2 × 60 ml). The combined ethyl acetate extracts were dried with anhydrous 
MgSO4. Ethyl acetate was removed under vacuo and a brown liquid (5 mg) was 
obtained. This brown liquid was not identified. 
Second Attempt 
Compounds 3 (266 mg, 2.00 mmol) and 2a (140 mg, 2.00 mmol) were dissolved in 
acetonitrile (8 ml). 2,6-Lutidine (0.466 ml, 4.00 mmol), DIPEA (0.696 ml, 4.00 mmol) 
and copper(I) iodide (38 mg, 0.2 mmol) were added to the reaction mixture. The 
reaction mixture was stirred at room temperature for 4 h. Acetonitrile was removed 
under vacuo. The crude product was dissolved in ethyl acetate (150 ml) and washed 
with 0.1 N HCl (2 × 20 ml). The ethyl acetate portion was dried with anhydrous 
MgSO4 and subsequently concentrated. The crude product was purified by column 
chromatography with ethyl acetate/ pentane as solvent (gradient elution).  
Band 1 
A white solid was obtained and is assigned to be the decarboxylated product, 5.  
Yield: 110 mg (35 %)  
1H NMR (acetone-d6): δ 8.02 (s, 1H, triazole), 7.72 (s, 1H, triazole) 7.45-7.34 (m, 5H, 
aromatic H), 5.69 (s, 2H, PhCH2) 
13C NMR (acetone-d6): δ 137.2, 129.6, 129.0, 128.7, 125.0, 53.9 
EI-MS: 159.1 [M]+ 
Band 2 
Analytically pure product can be obtained by recrystallization with dichloromethane/ 
hexane. The white solid obtained was assigned to be the target compound, 4a.  
Yield:  21 mg (5 %)  
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1H NMR (acetone-d6): δ 8.58 (s, 1H, triazole), 7.46-7.39 (m, 5H, aromatic H), 5.76 (s, 
2H, PhCH2) 
13C NMR (acetone-d6): δ 161.8, 140.8, 136.5, 129.8, 129.3, 129.0, 54.5 
EI-MS: 203.1 [M]+ 
 
3.3 Trial ‘click’ reaction of 4-pentynoic acid, 2b, and benzyl azide, 3 
First attempt 
Compounds 3 (266 mg, 2.00 mmol) and 2b (196 mg, 2.00 mmol) were dissolved in 
acetonitrile (8 ml). 2,6-Lutidine (0.466 ml, 4.00 mmol) and copper(I) iodide (120 mg, 
0.630 mmol) were added to the reaction mixture. The reaction mixture was stirred at 
room temperature for 4 h. Acetonitrile was removed under vacuo. The crude product 
was dissolved in ethyl acetate (150 ml) and washed with 0.1 N HCl (2 × 20 ml). The 
ethyl acetate portion was then extracted with 10 % Na2CO3 solution (2 × 20 ml). The 
Na2CO3 extracts were acidified to pH 1 and the product was extracted with ethyl 
acetate (2 × 50 ml). The ethyl acetate portions were dried with anhydrous MgSO4. 
Removal of ethyl acetate in vacuo affords the product, 4b, as a white solid.   
Yield: 300 mg (65 %) 
1H NMR (acetone-d6) δ 7.74 (s, 1H, triazole), 7.40-7.31 (m, 5H, aromatic H), 5.59 (s, 
2H, PhCH2), 2.96 (t, 2H, 3JHH = 7.46), 2.69 (t, 2H, 3JHH = 7.45) 
13C NMR (acetone-d6) δ 174.0, 147.4, 137.2, 129.6, 129.0, 128.8, 122.5, 54,1, 33.8, 
21.7 
EI-MS: 231.2 [M]+ 
Second attempt  
Compounds 3 (133 mg, 1.00 mmol) and 2b (98 mg, 1.00 mmol) were dissolved in 
THF (5 ml) and water (2 ml). Copper sulfate (10 mol %) in water (1 ml) and sodium 
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ascorbate (40 mol %) in water (2 ml) were added and the reaction mixture was stirred 
at room temperature for 4 h. THF was removed under vacuo and 0.1 N HCl was 
added to acidify the solution to pH 1. The crude product was extracted with ethyl 
acetate (2 × 60 ml). The combined ethyl acetate extracts were dried with anhydrous 
MgSO4. Ethyl acetate was removed under vacuo to afford the product, 4b, as a white 
solid. 
Yield: 160 mg (69 %) 
 
3.4 Synthesis of 1-(4-azidobutyl)thymine, 6  
1-(4-bromobutyl)thymine (140 mg, 0.54 mmol) and NaN3 (70 mg, 1.08 mmol) were 
dissolved in DMSO (8 cm3). The reaction mixture was stirred at 55 °C for 16 h. The 
reaction mixture was then diluted with water (20 ml). The crude product was 
extracted with dichloromethane (3 × 20 ml). The combined organic extracts were 
washed with water (20 ml), brine (20 ml) and dried over anhydrous MgSO4. Removal 
of dichloromethane in vacuo affords the compound as a white solid. Analytically pure 
product 6 can be obtained by recrystallization with dichloromethane/hexane.  
Yield:  90 mg (75 %) 
1H NMR (CDCl3): δ 8.89 (br, s, 1H, NH), 6.98 (s, 1H, CH), 3.73 (t, 2H, NCH2, 3JHH = 
7.20), 3.34 (t, 2H, CH2N3, 3JHH = 6.45), 1.92 (s, 3H, CH3), 1.81-1.56 (m, 4H, CH2CH2)  
13C NMR (CDCl3): δ 164.5 (C-4), 151.1 (C-2), 140.1 (C-6), 110.1 (C-5), 50.9 (CH2), 
47.8 (CH2), 26.4 (CH2), 25.8 (CH2), 12.3 (CH3) 
IR (CH2Cl2, cm-1): νNN 2098m 
EI-MS: 224 [M+H]+ 




3.5 ‘Click’ reaction of 4-pentynoic acid, 2b, with 1-(4-azidobutyl)thymine, 6 
Compounds 6 (111 mg, 0.500 mmol) and 2b (49 mg, 0.50 mmol) were dissolved in 
THF (3 ml). Copper sulfate (10 mol %) in water (1 ml) and sodium ascorbate (40 mol 
%) in water (2 ml) were added and the reaction mixture stirred at room temperature 
for 4 h. The solvent was removed under vacuo. The product, 7, was purified by 
recrystallization from methanol.  
Yield: 30 mg (19 %) 
1H NMR (DMSO-d6): δ 11.20 (br, s, 1H, NH), 7.83 (s, 1H, triazole), 7.49 (s, 1H, CH), 
4.31 (t, 2H, CH2-triazole, 3JHH = 6.87), 3.63 (t, 2H, NCH2, 3JHH = 6.87), 2.83 (t, 2H, 
CH2, 3JHH = 7.40), 2.56 (t, 2H, CH2, 3JHH = 7.44), 1.80-1.71 (m, 2H, CH2), 1.74 (s, 3H, 
CH3), 1.57-1.48 (m, 2H, CH2)  
13C NMR (DMSO-d6): δ 179.5 (CO2H), 164.2 (C-4), 150.9 (C-2), 145.6 (C of 
triazole), 141.3 (C-6), 121.9 (CH of triazole), 108.5 (C-5), 48.7 (CH2), 46.4 (CH2), 
33.2 (CH2), 26.7 (CH2), 25.5 (CH2), 20.6 (CH2), 11.8 (CH3)  
CI-MS: 339 [M + NH4]+, 322 [M + H]+   
 
3.6 Synthesis of 2-prop-2ynyl-malonic acid diethyl ester 
Diethyl malonate (1.8 g, 11.3 mmol) was dissolved in THF (15 ml) and the solution 
cooled to 0 °C. Sodium hydride (0.4 g, 60% dispersion in mineral oil, 10.0 mmol) was 
added and the reaction mixture was stirred at 0 °C for 1 h. Subsequently, propargyl 
bromide (1.19 g, 10.0 mmol) was added at 0 °C. The mixture was gradually warmed 
to room temperature and stirred for 1 h 30 min. THF was removed in vacuo. The 
reaction mixture was diluted with diethyl ether (180 ml), and washed with water (2 × 
50 ml) and brine (50 ml). The organic phase was then dried over anhydrous MgSO4.   
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The filtrate was concentrated and purified by column chromatography with 4:1 
dichloromethane: pentane as eluant. Band 2 was identified to be 2-prop-2-ynyl-
malonic acid diethyl ester. The product was obtained as a colourless oil. 
Yield: 800 mg (36 %) 
1H NMR (CDCl3): δ 4.21 (q, 4H, CH2 of Et, 3JHH = 7.03), 3.54 (t, 1H, CH, 3JHH = 
7.71), 2.76 (dd, 2H, CH2, 3JHH = 7.71, 4JHH = 2.64), 2.00 (t, 1H, ≡CH, 4JHH = 2.64), 
1.26 (t, 6H, CH3 of Et, 3JHH = 7.15) 
13C NMR (CDCl3): δ167.8, 79.9, 70.3, 61.7, 51.1, 18.3, 14.0 
 
3.7 Synthesis of 2-prop-2-ynyl-malonic acid, 9 
Potassium hydroxide (1.3 g, 23.2 mmol) was dissolved in ethanol (60 ml) and heated 
to 50 °C. 2-prop-2-ynyl-malonic acid diethyl ester (500 mg, 2.52 mmol) was added to 
the ethanolic potassium hydroxide solution and the reaction mixture was heated at 50 
°C for 4 h. The reaction mixture was concentrated, diluted with water (50 ml) and 
washed with diethyl ether (2 × 15 ml). The alkaline aqueous solution was then 
acidified to pH 1. The crude compound was extracted with diethyl ether (3 × 30 ml) 
and the combined ether extracts were dried over anhydrous MgSO4.  Removal of ether 
in vacuo afforded the compound as a colourless crystalline solid. Analytically pure 
product can be obtained by recrystallization with ether/hexane. 
Yield: 180 mg (22 %)  
1H NMR (acetone-d6): δ 3.60 (t, 1H, CH, 3JHH = 7.62), 2.72 (dd, 2H, CH2, 3JHH = 7.40, 
4JHH = 2.61), 2.43 (t, 1H, ≡CH, 4JHH = 2.73) 
13C NMR (acetone-d6): δ 169.5, 81.3, 71.6, 51.5, 18.8 
Calc. for C6H6O4 (%): C, 50.71; H, 4.26. Found: C, 50.73; H, 4.29. 
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3.8 ‘Click’ reaction between 9 and 1-(4-azidobutyl)thymine, 6 
Compounds 6 (157 mg, 0.7 mmol) and 9 (100 mg, 0.7 mmol) were dissolved in THF 
(4 ml). Copper sulfate (10 mol %) in water (1.2 ml) and sodium ascorbate (40 mol %) 
in water (2.8 ml) were added and the reaction mixture stirred at room temperature for 
4 h. The solvent was removed under vacuo. Recrystallization from methanol/ diethyl 
ether affords the product as a white solid, 10.     
Yield: 25 mg (10%) 
1H NMR (DMSO-d6): δ 11.20 (br, s, 1H, NH), 7.75 (s, 1H, triazole), 7.48 (s, 1H, CH), 
4.31 (t, 2H, CH2-triazole, 3JHH = 6.87), 3.63 (t, 2H, NCH2, 3JHH = 6.78), 3.42 (m, 1H, 
CH(CO2H), splitting pattern is unclear due to overlap with impurity), 3.09 (d, 2H, 
CH2, 3JHH = 6.21), 1.78-1.74 (m, 5H, CH3 and CH2), 1.53-1.49 (m, 2H, CH2) 
13C NMR (DMSO-d6): δ 171.2 (CO2H), 164.2 (C-4), 150.9 (C-2), 141.3 (C-6), 122.3 
(CH of triazole), 108.5 (C-5), 48.6 (CH2), 46.4 (CH2), 26.7 (CH2), 25.4 (CH2), 24.8 
(CH2), 11.8(CH3) (C of triazole and CH(CO2H) not observed) 
 
3.9 Reaction of 7 with Os3(CO)10(NCMe)2, 1 
Compounds 7 (30 mg, 0.093 mmol) and 1 (100 mg, 0.107 mmol) were dissolved in 
THF (25 ml). The reaction mixture was stirred at room temperature for 24 h. THF was 
removed under vacuo and the crude product was purified by column chromatography 
with 4:1 ethyl acetate: pentane as eluant. The major yellow band was assigned as A1.  
Yield: 25 mg (23 %) 
1H NMR (CDCl3): δ 8.42 (br, s, 1H, NH), 7.46 (s, 1H, triazole), 6.97 (s, 1H, CH), 
4.15 (br s, 2H, CH2-triazole), 3.78 (br s, 2H, NCH2), 2.60-2.56 (m, 4H, 2 CH2), 1.93 
(s, 3H, CH3), 1.91-1.82 (m, 4H, 2 CH2), −10.47 (OsHOs) 
IR (CH2Cl2, cm-1): νCO 2114w, 2083sh, 2076s, 2063s, 2028vs, 2015vs, 1975s, 1946 m 
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FAB-MS: 2022.5 [M+H]+ 
 
3.10 Reaction of 5 with Os3(CO)10(NCMe)2, 1 
 Compounds 5 (16 mg, 0.101 mmol) and 1 (50 mg, 0.054 mmol) were dissolved in 
THF (15 ml). The reaction mixture was stirred at room temperature for 16 h. THF was 
removed under vacuo and the crude product was purified by column chromatography 
with 1:1 dichloromethane: hexane as eluant. The major yellow band was isolated and 
assigned as B1.  
Yield: 45 mg (83 %) 
1H NMR (CDCl3): δ 7.69 (d, 1H, triazole, 3JHH = 1.23), 7.53-7.51 (m, 3H, aromatic H),   
7.33-7.30 (m, 2H, aromatic H), 7.14 (d, 1H, triazole, 3JHH = 1.23), 5.26 (d, 1H, PhCH2, 
2JHH = 14.46), 5.16 (d, 1H, PhCH2, 2JHH = 14.49)  
IR (CH2Cl2, cm-1): νCO 2084m, 2029s, 2018vs, 2003m, 1975m, 1956w 
FAB-MS: 1010.8 [M+H]+ 
B1 decomposed when left in chloroform after one day. 25 mg of B1 was left in 
chloroform for six days. The resulting mixture was subjected to TLC using 1:3 
dichloromethane: hexane as eluant.    
Band 1 (Yellow) Rf = 0.90 
Yield: 3 mg 
This compound was identified as Os3(CO)12. 
IR (CH2Cl2, cm-1): νCO 2069vs, 2034s, 2013w, 2000w 
Band 2 (Yellow) Rf = 0.50 
Yield: 6 mg 
1H NMR (CDCl3): δ 7.38-7.36 (m), 7.33-7.30 (m), 6.91 (s), 5.45 (d, 2JHH = 14.46), 
5.31 (d, 2JHH = 14.88), −15.33 (s)    
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IR (CH2Cl2, cm-1): νCO 2105w, 2066vs, 2054s, 2019s, 2010m, 1992w,  
Band 3 (Yellow) Rf = 0.09 
Yield: 3 mg. This band was not characterized. 
Band 4 (Brown) Baseline 
This band was not characterized.  
 
3.11 Reaction of 4b with Os3(CO)10(NCMe)2, 1 
Compounds 4b (26 mg, 0.113 mmol) and 1 (150 mg, 0.161 mmol) were dissolved in 
THF (25 ml). The reaction mixture was stirred at room temperature for 16 h. THF was 
removed under vacuo and the crude product was purified by column chromatography. 
Three yellow bands were isolated.  
Band 1 
The compound is eluted with 1:1 dichloromethane: hexane and assigned as A2.  
Yield: 25 mg (11 %) 
1H NMR (CDCl3) δ 7.54-7.52 (m, 3H, aromatic H), 7.31-7.38 (m, 2H, aromatic H), 
6.77 (s, 1H, triazole), 5.19 (d, 1H, PhCH2, 2JHH = 14.49), 5.05 (d, 1H, PhCH2, 2JHH = 
14.46), 2.58-2.52 (m, 4H, CH2CH2), −10.53 (s, 1H, OsHOs)  
IR (CH2Cl2, cm-1): νCO 2114w, 2083m, 2077s, 2063s, 2029vs, 2017vs, 1975m, 1950 m 
FAB-MS: 1934.2 [M+H]+ 
Band 2 
This band is eluted with 4:1 dichloromethane: hexane.  
Yield: 10 mg (5 %) 
1H NMR (CDCl3) 7.38-7.36 (m, 3H), 7.29-7.24 (m, overlap with solvent peak), 7.10 
(s, 1H), 5.47 (s, 2H), 2.84-2.77 (t, 2H, 3JHH = 7.23), 2.68-2.64 (t, 2H, 3JHH = 7.23), 
−10.50 (s, 1H)    
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IR (CH2Cl2, cm-1): νCO 2114w, 2076s, 2063s, 2026vs, 2015vs, 1979m 
Band 3 
This compound is eluted with 1:1 methanol: chloroform and is assigned as B2. 
Yield: 60 mg (30 %) 
1H NMR (acetone-d6)  δ 8.46 (s, 1H, triazole), 7.42 (br s, 5H, aromatic H), 5.58 (br s, 
1H, PhCH2), 5.43 (br s, 1H, PhCH2), 2.70 (br s, 2H, CH2), 2.43 (br s, 2H, CH2)  
IR (CH2Cl2, cm-1): νCO 2085m, 2026s, 2017vs, 1975m, 1956w 
FAB-MS: 1081.9 [M−H]− 
 
3.12 Reaction of Os3(CO)10(NCMe)2, 1, with 4-pentynoic acid, 2b 
4-pentynoic acid (100 mg, 1.02 mmol), 2b, was added to the solution of 1 (150 mg, 
0.161mmol) in THF (25 ml). The reaction mixture was refluxed for 45 min. THF was 
removed under vacuo. The crude compound was purified by column chromatography 
with 1:1 dichloromethane: diethyl ether as eluant. Two yellow main yellow bands 
were identified. 
Band 1 
A yellow solid was obtained and is identified as Os3(CO)10(µ-H)(µ-
O2CCH2CH2C≡CH), 11b.  
Yield: 30 mg (20 %) 
1H NMR (CDCl3): δ 2.44 (t, 2H, CH2, 3JHH = 7.33), 2.26 (dt, 2H, CH2, 3JHH = 7.17, 
4JHH = 2.41), 1.94 (t, 1H, ≡CH, 4JHH = 2.70), −10.47 (s, 1H, OsHOs)  
13C NMR (CDCl3): δ 190.2, 183.9, 182.2, 176.5, 174.9, 174.8, 83.0, 69.7, 36.8, 15.6 
IR (CH2Cl2, cm-1): νCO 2113w, 2075vs, 2063s, 2024vs, 2014s, 1982m 
FAB-MS:  950.0 [M+H]+ 
Band 2 
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A yellow solid was obtained and is identified as Os3(CO)9(µ-CO)(µ3,η2-
HCCCH2CH2CO2H), 12. 
Yield: 60 mg (40 %) 
1H NMR (CDCl3): δ 9.17 (s, 1H, ≡CH), 2.86-2.35 (m, 4H, CH2CH2)  
IR (CH2Cl2, cm-1): νCO 2100w, 2064vs, 2052s, 2023m, 2004m, 1840vw (µ-CO), 
1605w (C=O) 
FAB-MS:  949.9 [M+H]+ 
Calc. for C15H6O12Os3 (%): C, 18.99; H, 0.64. Found: C, 19.05; H, 0.89. 
 
3.13 Reaction of Os3(CO)10(NCMe)2, 1, with 2-prop-2-ynyl-malonic acid, 9 
Cluster 1 (200 mg, 0.214 mmol) was added to a solution of 9 (15 mg, 0.105 mmol) in 
dichloromethane (15 ml). The reaction mixture was stirred at room temperature for 4 
h. Dichloromethane was removed under vacuo and the crude product was purified by 
column chromatography with 1:1 pentane: dichloromethane as eluant. The major 
yellow band was identified to be the cluster 14. 
Yield: 50 mg (48 %) 
1H NMR (CDCl3): δ4.75 (d, 1H, =CH2, 3JHH = 2.09), 4.33 (br s, 1H, =CH2), 3.58 (dd, 
1H, CH, 3JHH = 10.13, 3JHH = 8.43), 3.03-2.93 (m, 1H, CH2), 2.88-2.73 (m, 1H, CH2),    
−10.41 (s, 1H, OsHOs) 
IR (CH2Cl2, cm-1): νCO 2115w, 2078vs, 2064s, 2027vs, 2013vs, 1983m 
FAB-MS:  993.5 [M+H]+ 





3.14 Attempted alkylation of {Os3(CO)10(µ-H)(µ-O2C)}2CH2, 15  
NaH (2 mg, 60% dispersion in mineral oil, 0.05 mmol) was added to a solution of 15 
(80 mg, 0.044 mmol) in THF (5 ml). The reaction mixture was stirred at room 
temperature for 10 minute. Subsequently, propargyl bromide (3.3 µl, 0.044 mmol) 
was added and the reaction mixture as stirred at room temperature for 20 h. The 
reaction was monitored by TLC and 1H NMR, no conversion to the target compound 
was observed.  
 
3.15 Reaction of Os3(CO)10(NCMe)2, 1, with azido alkanoic acids 
Synthesis of Os3(CO)10(µ-H)(µ-O2CCH2CH2N3), 16a   
3-azidopropionic acid (100 mg, 0.870 mmol) and 1 (150 mg, 0.161 mmol) were 
dissolved in THF (30 ml). The reaction mixture was refluxed for 2 h. THF was 
removed under vacuo. The crude product was dissolved in dichloromethane and 
filtered. The filtrate was concentrated and purified by column chromatography with 
1:4 dichloromethane: pentane as eluant. The major yellow band was identified to be 
the product, 16a. 
Yield: 30 mg (19 %)  
1H NMR (CDCl3): δ3.29 (t, 2H, CH2N3, 3JHH = 6.3), δ2.48 (t, 2H, CH2, 3JHH = 6.3), 
−10.45 (s, 1H, OsHOs) 
13C NMR (CDCl3)  δ 189.4, 184.3, 182.1, 176.4, 174.8, 174.7, 174.6, 47.7, 36.9  
IR (CH2Cl2, cm-1): νCO 2113w, 2076vs, 2063s, 2025vs, 2014s, 1981m 
FAB-MS:  966.9 [M+H]+ 




Synthesis of Os3(CO)10(µ-H)(µ-O2CCH2CH2CH2CH2N3), 16b  
Cluster 16b was synthesized using a similar procedure from the reaction of 1 (150 mg, 
0.161 mmol) and 6-azidohexanoic acid (280 mg, 1.870 mmol). 
Yield: 70 mg (37 %) 
1H NMR (CDCl3): δ3.23 (t, 2H, CH2N3, 3JHH = 6.83), δ2.22 (t, 2H, CH2CO2, 3JHH = 
7.53), 1.58-1.51 (m, 2H), 1.48-1.36 (m, 2H), 1.28-1.20 (m, 2H), −10.50 (s, 1H, 
OsHOs) 
13C NMR (CDCl3)  δ 192.1, 183.7, 182.3, 176.6, 175.0, 174.9, 174.8, 51.8, 37.5, 29.1, 
26.9, 25.5  
IR (CH2Cl2, cm-1): νCO 2113w, 2075vs, 2062s, 2025vs, 2014s, 1982m 
FAB-MS:  1009.0 [M]+ 
HR-FAB: C16H11O12N3192Os3 (M)+ calcd m/z 1012.9182, found 1012.9177 
 
3.16 Synthesis of Os3(CO)10(µ-H)(µ-O2CCH2CH2Br), 17    
3-bromopropionic acid (40 mg, 0.26 mmol) and 1 (150 mg, 0.161 mmol) were 
dissolved in THF (25 ml). The reaction mixture was refluxed for 3 h. THF was 
removed under vacuo. The crude product was purified by column chromatography 
with 1:4 dichloromethane: pentane as eluant. The major yellow band was identified to 
be the product. Analytically pure product can be obtained by recrystallization with 
dichloromethane/hexane. 
Yield: 120 mg (75 %)  
1H NMR (CDCl3): δ3.35 (t, 2H, CH2Br, 3JHH = 6.8), δ2.81 (t, 2H, CH2, 3JHH = 6.8), 
−10.45 (s, 1H, OsHOs) 
13C NMR (CDCl3)  δ 188.9, 184.2, 182.1, 176.4, 174.7, 174.5, 41.1, 27.2  
IR (CH2Cl2, cm-1): νCO 2114w, 2076vs, 2063s, 2025vs, 2014s, 1984m 
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FAB-MS: 1003.7 [M+H]+  
Calc. for C13H5O12BrOs3 (%):  C, 15.56; H, 0.50. Found: C, 15.43; H, 0.43.  
 
3.17 Attempted azidation of 17 
First attempt  
NaN3 (20 mg, 0.31 mmol) and 17 (72 mg, 0.072 mmol) were dissolved in DMF. The 
reaction mixture was stirred at room temperature for 24 h. DMF was removed under 
vacuo. The reaction was monitored by TLC and no conversion to target compound 
was observed.  
Second attempt 
Trimethylsilyl azide (30 µl, 0.45 mmol) was added to 0.3 ml of 1 M 
tetrabutylammonium fluoride (0.3 mmol) solution. The reaction mixture was stirred at 
40 °C for 30 min, 17 (130 mg, 0.13 mmol) in THF (10 ml) was then added to the 
reaction mixture. Bubbles were seen and the solution turned from yellow to orange. 
The reaction was monitored by TLC. After five minutes, no starting material 
remained but the target compound was not formed. Removal of THF under vacuo 
afforded an orange oil. This orange compound was unstable and turned brown after a 
few minutes when left in solution or exposed to air. The orange compound was only 
characterized by IR spectroscopy.  
IR (THF, cm-1): νCO 2098w, 2071m, 2048s, 2018vs, 2004s, 1977 vs, 1955 m 
  
3.18 Synthesis of 3-(4-bromobutyl)thymidine 
1,4-dibromobutane (625 mg, 2.89 mmol) was added to a solution of thymidine (500 
mg, 2.07 mmol) and potassium carbonate (855 mg, 6.20 mmol) in DMF/acetone (12 
ml, 1:1). The reaction mixture was heated at 65 °C for 6 h. Acetone was removed 
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under vacuo. Subsequently, water (100 ml) was added to the reaction mixture. The 
crude compound was extracted with ethyl acetate (2 × 50 ml). The ethyl acetate 
portions were washed with water (50 ml), brine (50 ml) and dried with anhydrous 
MgSO4.  Ethyl acetate was removed under vacuo and the crude product was washed 
with pentane to yield a white gum.  
Yield: 300 mg (38 %)  
1H NMR (CDCl3): δ 7.47 (s, 1H, H-6), 6.20 (t, 1H, H-1’, 3JHH = 6.68 Hz), 4.51-4.47 
(m, 1H, H-3’), 3.98-3.76 (m, 5H, H-4’, H-5’, CH2N), 3.39 (t, CH2Br, 3JHH = 6.50 Hz), 
2.34-2.22 (m, 2H, H-2’), 1.87-1.62 (m, 7H, 2CH2, CH3)   
13C NMR (CDCl3)  δ 164.1 (C-4), 151.5 (C-2), 135.4 (C-6), 110.8 (C-5), 87.6 (C-4’), 
87.3 (C-1’), 72.0 (C-3’), 62.9 (C-5’), 41.0 (CH2), 40.8 (CH2), 33.9 (CH2), 30.6 
(CH2Br), 26.9 (CH2), 13.9 (CH3)   
HR-ESI: C14H20O2N2Br (M−H)− calcd 377.530, found 377.0535  
 
3.19 Synthesis of 3-(4-azidobutyl)thymidine, 18 
3-(4-bromobutyl)thymidine (300 mg, 0.80 mmol) and NaN3 (104 mg, 1.59 mmol) 
were dissolved in DMSO (10 cm3). The reaction mixture was stirred at 55 °C for 16 h. 
The reaction mixture was then diluted with water (40 ml). The crude product was 
extracted with dichloromethane (2 × 40 ml). The combined organic extracts were 
washed with water (40 ml), brine (40 ml) and dried over anhydrous MgSO4. Removal 
of the ethyl acetate in vacuo affords the compound, 18, as a colorless oil.  
Yield:  180 mg (66 %) 
1H NMR (CDCl3): δ 7.46 (s, 1H, H-6), 6.20 (t, 1H, H-1’, 3JHH = 6.41 Hz), 4.47 (br s, 
1H, H-3’), 3.95-3.75 (m, 5H, H-4’, H-5’, CH2N), 3.26 (t, CH2N3, 3JHH = 6.41 Hz), 
2.41-2.18 (m, 2H, H-2’), 1.86 (CH3), 1.72-1.52 (2CH2)   
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13C NMR (CDCl3)  δ 164.1 (C-4), 151.5 (C-2), 135.4 (C-6), 110.8 (C-5), 87.6 (C-4’), 
87.2 (C-1’), 71.9 (C-3’), 62.8 (C-5’), 51.6 (CH2N3), 41.2 (CH2), 40.7 (CH2), 26.8 
(CH2), 25.3 (CH2), 13.8 (CH3)   
ESI-MS: m/z 338.1 [M−H]− 
 
3.20 ‘Click’ reaction between 11a and 1-(4-azidobutyl)thymine, 6 
Compounds 11a (60 mg, 0.065 mmol) and 6 (12 mg, 0.054 mmol) were dissolved in 
acetonitrile (5 ml). To this solution, 2,6-lutidine (20 µl, 0.17 mmol) and copper(I) 
iodide (4 mg, 0.02 mmol) were added. The reaction mixture was stirred at room 
temperature for 5 h. The crude product was concentrated and purified by column 
chromatography with 4:1 ethyl acetate: pentane as eluant. The major yellow band was 
identified to be the product 21. 
Yield: 40 mg (64 %) 
1H NMR (CDCl3) δ 9.39 (br, s, 1H, NH), 7.85 (s, 1H, triazole), 6.91 (s, 1H, CH), 4.38 
(t, 2H, CH2-triazole, 3JHH = 6.87), 3.69 (2H, t, NCH2, 3JHH = 6.96), 1.96-1.58 (m, 4H, 
2 CH2), 1.88 (s, 3H, CH3), −10.23 (OsHOs) 
13C NMR (CDCl3)  δ 182.5, 177.3, 175.7, 174.4, 174.0, 173.9, 164.2 (C-4), 151.1 (C-
2), 141.4 (C of triazole), 139.8 (C-6), 127.2 (CH of triazole), 111.3 (C-5), 49.7 (CH2), 
47.1 (CH2), 26.8 (CH2), 25.9 (CH2), 12.3 (CH3) 
IR (CH2Cl2, cm-1): νCO 2114w, 2076vs, 2064s, 2026vs, 2016s, 1983m 
FAB-MS: 1145.7 [M+H]+  





3.21 ‘Click’ reaction between 11a and 3-(4-azidobutyl)thymidine, 18 
Using the ‘click’ reaction conditions described in 3.20, 11a (80 mg, 0.087 mmol) and 
18 (25 mg, 0.074 mmol) were combined. The crude product was purified by column 
chromatography with 9:1 chloroform: methanol as eluant. The major yellow band was 
identified to be the product 22. 
Yield: 60 mg (65 %) 
1H NMR (CDCl3)  δ 7.89 (s, 1H, triazole), 7.47 (s, 1H, H-6), 6.19 (t, 1H, H-1’, 3JHH = 
6.41 Hz), 4.59-4.55 (m, 1H, H-3’), 4.37 (t, 2H, CH2-triazole), 4.00-3.80 (m, 5H, H-4’, 
H-5’, CH2N), 2.35-2.31 (m, 2H, H-2’), 1.93-1.82 (m, 5H, CH3, CH2), 1.72-1.57 (m, 
2H, CH2), −10.24 (OsHOs) 
13C NMR (CDCl3)  δ 183.0, 182.1, 176.4, 175.0, 174.7, 174.6, 164.1 (C-4), 151.6 (C-
2), 141.8 (C of triazole), 135.8 (C-6), 128.0 (CH of triazole), 110.8 (C-5), 87.7 (C-4’ 
and C-1’ overlap), 72.0 (C-3’), 62.9 (C-5’), 50.6 (CH2), 40.9 (CH2), 40.6 (CH2), 28.0 
(CH2), 25.0 (CH2), 13.9 (CH3)   
IR (CH2Cl2, cm-1): νCO 2114w, 2076vs, 2064s, 2025vs, 2015s, 1985m 
FAB-MS: 1262.0 [M+H] + 
HR-FAB: C27H24O17N5190Os1192Os2 (M+H)+ calcd m/z 1263.9976, found 1264.0017 
     
3.22 ‘Click’ reaction between 11a and 5’-azido-5’-deoxythymidine, 19 
Using the ‘click’ reaction conditions described in 3.20, 11a (80 mg, 0.087) and 19 (18 
mg, 0.067 mmol) were combined. The crude product was purified by column 
chromatography with 9:1 chloroform:methanol as eluant. The major yellow band was 
identified to be the product 23. 
Yield: 60 mg (75 %) 
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1H NMR (CDCl3)  δ 9.73 (br, s, 1H, NH), 7.95 (s, 1H, triazole), 6.73 (s, 1H, H-6), 
6.07 (t, 1H, H-1’, 3JHH = 6.50 Hz), 4.74-4.60 (m, 2H, H-5’), 4.55-4.51 (m, 1H, H-3’), 
4.19-4.16 (m, 1H, H-4’), 2.39-2.24 (m, 2H, H-2’), 1.84 (s, 3H, CH3), −10.22 (OsHOs) 
13C NMR (CDCl3)  δ 181.9, 177.8, 176.3, 175.1, 174.8, 174.4, 164.5 (C-4), 151.2 (C-
2), 141.8 (C of triazole), 137.1 (C-6), 129.3 (CH of triazole), 112.3 (C-5), 87.2 (C-4’), 
84.2 (C-1’), 72.1 (C-3’), 39.5, 30.4, 13.2 (CH3)   
IR (CH2Cl2, cm-1): νCO 2114w, 2076vs, 2064s, 2026vs, 2016s, 1983m 
FAB-MS: 1189.2 [M−H]− 
Calc. for C23H15N5O16Os3 (%): C, 23.25; H, 1.27; N, 5.89. Found: C, 23.53; H, 1.56; 
N, 5.65. 
 
3.23 ‘Click’ reaction between 11a and 3’-azido-3’-deoxythymidine, 20 
Using the ‘click’ reaction conditions described in 3.20, 11a (80 mg, 0.087 mmol) and 
20 (14 mg, 0.052 mmol) were combined. The crude product was purified by column 
chromatography with 19:1 chloroform: methanol as eluant. The major yellow band 
was identified to be the product 24. 
Yield: 38 mg (62 %) 
1H NMR (CDCl3)  δ 9.15 (br, s, 1H, NH), 7.98 (s, 1H, triazole), 7.37 (s, 1H, H-6), 
6.13 (t, 1H, H-1’, 3JHH = 6.62 Hz), 5.49-5.43 (m, 1H, H-3’), 4.37 (br s, 1H, H-4’), 
3.99 (d, 1H, H-5’, 2JHH = 12.41 Hz), 3.73 (d, 1H, H-5’, 2JHH = 12.41 Hz), 3.02-2.86 
(m, 2H, H-2’), 1.91 (s, 3H, CH3), −10.23 (OsHOs) 
The 1H assignments were confirmed by COSY. 
13C NMR (acetone-d6)  δ 184.5, 183.7, 179.5, 178.1, 176.5, 176.1, 165.3 (C-4), 152.1 
(C-2), 142.7 (C of triazole), 138.0 (C-6), 130.0 (CH of triazole), 111.7 (C-5), 86.7 (C-
4’), 86.5 (C-1’), 62.7 (C-5’), 61.7 (C-3’), 36.9 (C-2’), 13.3 (CH3) 
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IR (CH2Cl2, cm-1): νCO 2114w, 2076vs, 2064s, 2027vs, 2015s, 1983m 
FAB-MS: 1189.2 [M−H]− 
Calc. for C23H15N5O16Os3 (%): C, 23.25; H, 1.27; N, 5.89. Found: C, 23.15; H, 1.49; 
N, 5.45. 
 
3.24 Click reaction between Os3(CO)10(µ-H)(µ-O2CCH2CH2N3), 16a, and 3-(2-
propyn-1-yl)thymidine, 25 
 
Using the ‘click’ reaction conditions described in 3.20, 16a (120 mg, 0.124 mmol) 
and 25 (50 mg, 0.18 mmol) were combined. The crude product was purified by 
column chromatography with 4:1 chloroform:methanol as eluant. The major yellow 
band was identified to be the product 26a. 
Yield:  80 mg (52 %) 
1H NMR (CDCl3) 7.58 (s, 1H, triazole), 7.54 (s, 1H, H-6), 6.23 (t, 1H, H-1’, 3JHH = 
6.41 Hz), 5.18 (s, 2H, CH2N), 4.58 (br s, 1H, H-3’), 4.33 (t, 2H, CH2-triazole, 3JHH = 
6.69 Hz), 4.00 (br s, 1H, H-4’), 3.86 (br s, 2H, H-5’), 2.86 (t, 2H, CH2CO2, 3JHH = 
6.59 Hz), 2.30 (br s, 2H, C2’), 1.90 (s, 3H, CH3),  −10.47 (OsHOs) 
13C NMR (acetone-d6) δ 189.5, 184.5, 183.0, 177.4, 175.6, 175.0, 163.4 (C-4), 151.6 
(C-2), 143.9 (C of triazole), 135.7 (C-6), 124.5 (CH of triazole), 109.9 (C-5), 88.6 (C-
4’), 86.4 (C-1’), 72.1 (C-3’), 62.8 (C-5’), 46.5 (CH2), 41.2 (CH2), 37.9 (CH2), 36.8 
(CH2), 13.3 (CH3)  
IR (CH2Cl2, cm-1): νCO 2116w, 2076vs, 2063s, 2026vs, 2013s, 1983m 
FAB-MS: 1247.9 [M+H]+ 





3.25 Click reaction between Os3(CO)10(µ-H)(µ-O2CCH2CH2CH2CH2CH2N3), 16b, 
and 3-(2-propyn-1-yl)thymidine, 25 
 
Using the ‘click’ reaction conditions described in 3.20, 16b (80 mg, 0.079 mmol) and 
25 (20 mg, 0.071 mmol) were combined. The crude product was purified by column 
chromatography with 19:1 chloroform:methanol as eluant. The major yellow band 
was identified to be the product 26b. 
Yield:  50 mg (55 %) 
1H NMR (CDCl3) 7.63 (s, 1H, H-6), 7.60 (s, 1H, triazole), 6.23 (t, 1H, H-1’, 3JHH = 
6.41 Hz), 5.18 (s, 2H, CH2N), 4.60-4.56 (m, 1H, H-3’), 4.23 (t, 2H, CH2-triazole, 3JHH 
= 7.23 Hz), 3.99 (br s, 1H, H-4’), 3.87 (br s, 2H, H-5’), 2.40-2.29 (m, 2H, C2’), 2.19 
(2H, CH2CO2, 3JHH = 7.46 Hz), 1.88 (s, 3H, CH3), 1.83-1.76 (m, 2H, CH2CH2-
triazole), 1.45-1.35 (m, 2H, CH2CH2CO2), 1.21-1.11 (m, 2H, CH2CH2CH2-triazole), 
−10.51 (OsHOs) 
13C NMR (CDCl3) δ 191.9, 183.7, 182.2, 176.5, 175.0, 174.8, 174.7, 163.9 (C-4), 
151.4 (C-2), 143.6 (C of triazole), 136.0 (C-6), 124.5 (CH of triazole), 110.6 (C-5), 
87.9 (C-4’), 87.2 (C-1’), 71.2 (C-3’), 62.5 (C-5’), 50.8 (CH2-triazole), 40.9 (C-2’), 
37.4 (CH2CO2), 30.4 (CH2CH2-triazole), 26.6 (CH2CH2CH2-triazole), 25.3, 
(CH2CH2CO2), 13.8 (CH3)  
The 1H and 13C assignments were confirmed by COSY, HMQC and HMBC. 
IR (CH2Cl2, cm-1): νCO 2113w, 2075vs, 2062s, 2025vs, 2015s, 1981m 
FAB-MS: 1289.8 [M]+ 
HR-FAB: C29H27O17N5188Os1192Os2 (M)+ calcd m/z 1289.0185, found 1289.0192 
 
3.26 Crystallography studies of 12, 14 and 21 
Crystals of diffraction quality were grown by slow evaporation of a dichloromethane/ 
hexane mixture for 12, of a chloroform/hexane mixture for 14, and of a THF/hexane 
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mixture for 21. X-ray crystallographic data were collected on a Bruker APEX 
diffractometer equipped with a CCD detector, employing Mo Kα radiation (λ = 
0.71073 Å), at 100 K with the SMART suite of programs.9 Data were processed and 
corrected for Lorentz and polarisation effects with SAINT,10 and for absorption 
effects with SADABS.11 Structural solution and refinement were carried out with the 
SHELXTL suite of programs.12 For cluster 12, there are two molecules in the 
asymmetric unit, one of which (molecule A) shows disorder of one Os and a CO 
ligand; modeled with two sites with occupancies of 80 and 10%. For cluster 21, there 
are two THF solvates. Crystal and refinement data of 12, 14 and 21 are summarised in 
Table 3.1. 
Table 3.1. Crystallographic table for clusters 12, 14 and 21. 
Clusters 12 14 21 
Empirical formula C15H6O12Os3 C16H6O14Os3 C30H31N5O16Os3 
Formula weight 948.80 992.81 1288.20 
Crystal color and 
habit 
Red, block Yellow, block Yellow, block 
Crystal size, mm3 0.26 x 0.20 x 0.12 0.28 x 0.22 x 0.14 0.30 x 0.12 x 0.08 
Crystal system Monoclinic Monoclinic Triclinic 
Space group C2/c P21/c P⎯1 
A, Å 38.5572(17) 15.714(2) 10.7929(13) 
B, Å 9.0567(4) 9.4129(13) 10.9506(14) 
C, Å 27.3734(13) 15.062(2) 17.601(2) 
α, deg 90 90 104.903(2) 
β, deg 124.9860(10) 108.609(2) 92.315(2) 
γ, deg 90 90 110.644(2) 
Volume, Å3 7831.5(6) 2111.4(5) 1861.3(4) 
Z 16 4 2 
Density, Mgm-3 3.219 3.123 2.299 
Abs. coefficient, 
mm-1 
19.484 18.081 10.292 
F(000) 6720 1768 1204 
θ range for data 2.14 to 26.37 2.56 to 26.37 2.04 to 26.37 
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collection 









No. of reflections 
collected 




[R(int) = 0.0517] 
4323 
[R(int) = 0.0517] 
 
7634 
[R(int) = 0.0388] 
Data/ restraints/ 
parameters 
8011 / 0 / 556 4323 / 0 / 302 7634 / 0 / 496 
Goodness-of-fit on 
F2 
1.091 1.089 1.037 
Final R indices 
[I>2σ (I)] 
R1 = 0.0392, 
wR2 = 0.0838 
R1 = 0.0258, wR2 
= 0.0621 
R1 = 0.0265, 
wR2 = 0.0649 
R indices (all data) R1 = 0.0484, 
wR2 = 0.0873 
R1 = 0.0292, wR2 
= 0.0635 
R1 = 0.0294, 
wR2 = 0.0665 
Largest diff. peak 
and hole, e.Å-3 
2.514 and -1.106 1.819 and -1.041 2.524 and -0.735 
 
3.27 Computational studies 
All computations were of the closed-shell restricted Hartree-Fock type (RHF) and 
were performed on Sony VAIO laptops equipped with either a Pentium® Core 2 Duo 
processor or a Pentium® M processor. Facio 3D-graphics program13 and 
wxMacMolPlt14 were used for molecular orbital and geometry visualizations.       
Geometrical optimizations and SCF calculations for propiolic acid, 2a, and 4-
pentynoic acid, 2b, were carried out using the MOPAC2009 software15 with the semi-
empirical parametric method number 6 (PM6)16. Default optimization criterions were 
adopted for all calculations. The optimized structures and the corresponding HOMOs 
thus obtained are shown in Figure 3.1.    
DFT calculations were carried out using the PC GAMESS/Firefly17 ab initio quantum 
chemistry package, with the Becke-3-Lee-Yang-Parr (B3LYP1) density functional 
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method18,19 and the Stevens-Basch-Krauss-Jansien-Cundari (SBKJC) basis set.20  
Stationary point geometry search was done using the Rational Function Optimization 
algorithm. The SCF density convergence criteria (NCONV) and the gradient 
convergence tolerance (OPTTOL) were set as 10-5 and 10-4, respectively.  
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